openPR Logo
Press release

2017-2022 Global Trial Tracking Factbook market trend, analysis & overview

10-09-2017 02:53 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Reports Monitor

Trial Tracking Factbook Market Report

Trial Tracking Factbook Market Report

Trial Tracking Factbook Market 

ReportsMonitor has added a report on Trial Tracking Factbook Market.

Innovation and Clinical Trial Tracking Factbook 2017: An Assessment of the Pharmaceutical Pipeline” is a all-inclusive, granular analysis of the 25,522 products currently in the pharmaceutical industry pipeline, from the Deed stage through to Pre-registration and divided into therapy areas and key indications. This pipeline is also standard against its size across each segment compared to 2015 and 2016, and an assessment of the level of first-in-class innovation is provided. In addition, a detailed discourse analysis of the key drivers of this pipeline is provided, in addition to an assessment of companies present in the pipeline and historical deal value and volume.

If you want sample of this Report -

https://www.reportsmonitor.com/request-sample/?post=207569 

Summary

GBI Research’s latest report, “Innovation and Clinical Trial Tracking Factbook 2017: An Assessment of the Pharmaceutical Pipeline” is a comprehensive, granular analysis of the 25,522 products currently in the pharmaceutical industry pipeline, from the Discovery stage through to Pre-registration and split into therapy areas and key indications. This pipeline is also standard against its size across each segment compared to 2015 and 2016, and an assessment of the level of first-in-class innovation is provided.

Scope

- What is the current size and composition of the pharmaceutical industry pipeline and how has it changed in the last two years? What can we learn from this?

- The largest therapy area, by a substantial margin, is oncology, and, with growth in the pipeline sizes for all major oncology indications since Q1 2015, this trend appears set to continue. Why is this the case?

- What is the overall advantage for companies including first-in-class product developments in their pipeline portfolio, rather than opting for better-characterized established molecular targets?

Key Reasons to Purchase

- Achieve an up-to-date understanding of the landscape of the overall pharmaceutical pipeline, on both a broad and granular level; this also provides a highly accessible reference which is useful in any pharmaceutical strategic decision making process

- Benchmark key therapy areas and indications in terms of the number of pipeline products and level of innovation, and assess one’s own strategic positioning against this backdrop

If you want to check Discount on this Report -

https://www.reportsmonitor.com/check-discount/?post=207569

Table Of Contents

Table of Contents1 Table of Contents 2

1.1 List of Tables 3

1.2 List of Figures 3

2 Introduction 5

2.1 Increasing Cost of Drug Development 7

2.2 Most Drugs Fail to Recuperate R&D Costs 8

2.3 Contracting Life Cycles for Approved Products 9

2.4 The Case for First-in-Class Pharmaceutical Innovation 10

2.5 Conclusion 13

3 Assessment of the Pharmaceutical Industry Pipeline 14

3.1 Pipeline and Clinical Trials Landscape by Therapy Area 14

3.2 Pipeline by Stage of Development 19

3.3 Pipeline by Molecule Type 22

3.4 Key Therapy Areas by Indication 26

3.4.1 Oncology 26

3.4.2 Infectious Diseases 27

3.4.3 Central Nervous System 29

3.4.4 Immunology 32

3.5 Conclusion 33

4 Assessment of Innovation in the Pharmaceutical Industry Pipeline 34

4.1 First-in-Class Innovation by Stage of Development 36

4.2 Key Therapy Areas by Indication 37

4.2.1 Oncology 37

4.2.2 Infectious Diseases 40

4.2.3 Central Nervous System 43

Continue.......

Full Report Access -

https://www.reportsmonitor.com/innovation-and-clinical-trial-tracking-factbook-2017-an-assessment-of-the-pharmaceutical-pipeline/

Reports Monitor is a platform to meet the market research and business intelligence requirements. Our aim is to change the dynamics of the Market Research industry by providing quality intelligence backed by data. Your requirement for market forecasting is fulfilled by our exclusive quantitative and analytics driven intelligence. Decision makers can now rely on our distinct data gathering methods to get factual market forecasting and detailed analysis. Our process is meticulously planned and executed in order to use maximum resources and explore the market for getting genuine insights.

Address: Office C & D - 4th Floor, Siddhi Towers, Above Rupee Bank, Kondhwa Road, Pune 411048, Maharashtra, India

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release 2017-2022 Global Trial Tracking Factbook market trend, analysis & overview here

News-ID: 763348 • Views:

More Releases from Reports Monitor

Civil Engineering Design Software Market Share, Growth, Overview, Trends, CAGR and Forecast 2020-2025, Keyplayers - MicroStation,  AutoCAD,  SkyCiv etc.
Civil Engineering Design Software Market Share, Growth, Overview, Trends, CAGR a …
Civil Engineering Design Software Market 2020 The Civil Engineering Design Software industry has also suffered a certain impact, but still maintained a relatively optimistic growth. This Report covers the manufacturers’ data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market
Business Intelligence Platforms Software Market Share, Future Growth, CAGR and Forecast 2020-2025.
Business Intelligence Platforms Software Market Share, Future Growth, CAGR and F …
Business Intelligence Platforms Software Market 2020 The Business Intelligence Platforms Software industry has also suffered a certain impact, but still maintained a relatively optimistic growth. This Report covers the manufacturers’ data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market
Impact of Covid-19 on Brokerage Management Software Market - Current Scenario, Keyplayers - Brokermint, CoStar etc.
Impact of Covid-19 on Brokerage Management Software Market - Current Scenario, K …
Brokerage Management Software Market 2020 The Brokerage Management Software industry has also suffered a certain impact, but still maintained a relatively optimistic growth. This Report covers the manufacturers’ data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume
Impact of Covid-19 on Big Data Analytics Software Market 2020-2025, Keyplayers - Sisense, Looker, Zoho Analytics, etc.
Impact of Covid-19 on Big Data Analytics Software Market 2020-2025, Keyplayers - …
Big Data Analytics Software Market 2020 The Big Data Analytics Software industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years. This Report covers the manufacturers’ data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional

All 5 Releases


More Releases for Trial

Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025? The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025? The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with
Clinical Trial Imaging market
The Clinical Trial Imaging market crossed the US$ 1.09 billion mark in 2022 and is expected to hit US$ 1.94 billion by 2030, recording a CAGR of 7.5% during the forecast period. Rising R&D spending, a rapidly growing pharmaceutical industry, and an increase in the number of contract research organizations are some of the major factors driving the market's growth. There has been an increase in pharmaceutical companies due to the
Clinical Trial Management System
According to a new market report published by Persistence Market Research “Global Market Study on Clinical Trial Management System: Asia to Witness Highest Growth by 2019” the global clinical trial management system market was valued at USD 844.0 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of USD 1,848.5 million in 2019. Request Report TOC @ https://www.persistencemarketresearch.com/methodology/3017
Clinical Trial Logistics
Clinical Trial Logistics 16th to 17th May 2011, Marriott Regents Park, London, United Kingdom. It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical trials
Clinical Trial Logistics
Announcing SMi's 5th annual… Clinical Trial Logistics conference 16th and 17th May 2011, Central London, UK www.smi-online.co.uk/2011logistics-london6.asp It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical